WO2008033987A3 - Compositions et procédés de prévention du cancer avec des cupredoxines - Google Patents
Compositions et procédés de prévention du cancer avec des cupredoxines Download PDFInfo
- Publication number
- WO2008033987A3 WO2008033987A3 PCT/US2007/078371 US2007078371W WO2008033987A3 WO 2008033987 A3 WO2008033987 A3 WO 2008033987A3 US 2007078371 W US2007078371 W US 2007078371W WO 2008033987 A3 WO2008033987 A3 WO 2008033987A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- cupredoxins
- tissues
- animals
- development
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002663498A CA2663498A1 (fr) | 2006-09-14 | 2007-09-13 | Compositions et procedes de prevention du cancer avec des cupredoxines |
BRPI0714987-5A BRPI0714987A2 (pt) | 2006-09-14 | 2007-09-13 | composiÇÕes e mÉtodos para a prevenÇço do cÂncer com cupredoxina |
AU2007296429A AU2007296429A1 (en) | 2006-09-14 | 2007-09-13 | Compositions and methods to prevent cancer with cupredoxins |
MX2009002787A MX2009002787A (es) | 2006-09-14 | 2007-09-13 | Composiciones y métodos para prevenir el cáncer con cupredoxinas. |
EP07842403A EP2061498A4 (fr) | 2006-09-14 | 2007-09-13 | Compositions et procédés de prévention du cancer avec des cupredoxines |
JP2009528468A JP2010503409A (ja) | 2006-09-14 | 2007-09-13 | クプレドキシンによって癌を予防する組成物および方法 |
IL197602A IL197602A0 (en) | 2006-09-14 | 2009-03-15 | Compositions and methods to prevent cancer with cupredoxins |
NO20091267A NO20091267L (no) | 2006-09-14 | 2009-03-26 | Sammensetninger og fremgangsmåter for å forebygge kreft med cupredoxiner |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84435806P | 2006-09-14 | 2006-09-14 | |
US60/844,358 | 2006-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008033987A2 WO2008033987A2 (fr) | 2008-03-20 |
WO2008033987A3 true WO2008033987A3 (fr) | 2009-04-30 |
Family
ID=39184582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/078371 WO2008033987A2 (fr) | 2006-09-14 | 2007-09-13 | Compositions et procédés de prévention du cancer avec des cupredoxines |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2061498A4 (fr) |
JP (2) | JP2010503409A (fr) |
KR (1) | KR20090059152A (fr) |
CN (1) | CN101595124A (fr) |
AU (1) | AU2007296429A1 (fr) |
BR (1) | BRPI0714987A2 (fr) |
CA (1) | CA2663498A1 (fr) |
IL (1) | IL197602A0 (fr) |
MX (1) | MX2009002787A (fr) |
NO (1) | NO20091267L (fr) |
RU (1) | RU2009113812A (fr) |
SG (1) | SG174784A1 (fr) |
WO (1) | WO2008033987A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
JP2008515428A (ja) | 2004-10-07 | 2008-05-15 | チャクラバルティ、アナンダ | キュプレドキシンに由来する輸送因子及びそれを使用する方法 |
US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
US8232244B2 (en) | 2007-02-08 | 2012-07-31 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
US9598470B2 (en) * | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
AU2006269879A1 (en) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
JP2010511408A (ja) | 2006-12-04 | 2010-04-15 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | 癌をCpGリッチDNAおよびキュプレドキシンで治療するための組成物および方法 |
WO2019063097A1 (fr) * | 2017-09-29 | 2019-04-04 | Oncgnostics Gmbh | Détermination du risque de néoplasie et de cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
JP2008515428A (ja) * | 2004-10-07 | 2008-05-15 | チャクラバルティ、アナンダ | キュプレドキシンに由来する輸送因子及びそれを使用する方法 |
JP2008539795A (ja) * | 2005-05-20 | 2008-11-20 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ | キュプレドキシンを用いたエフリン信号伝達に関する症状を治療するための組成物および方法 |
MX2008000993A (es) * | 2005-07-19 | 2008-03-19 | Univ Illinois | Composiciones y metodos para controlar la angiogenesis con cupredoxinas. |
-
2007
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/fr active Application Filing
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/ja not_active Withdrawn
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/pt not_active Application Discontinuation
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/ko not_active Application Discontinuation
- 2007-09-13 CA CA002663498A patent/CA2663498A1/fr not_active Abandoned
- 2007-09-13 EP EP07842403A patent/EP2061498A4/fr not_active Withdrawn
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/ru unknown
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/es not_active Application Discontinuation
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/zh active Pending
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/no not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/ja active Pending
Non-Patent Citations (2)
Title |
---|
ARVIDSSON ET AL.: "The azurin gene from Pseudomonas aeruginosa cloning and characterization.", EUR. J. BIOCHEM., vol. 179, 1989, pages 195 - 200, XP008107831 * |
YAMADA ET AL.: "Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer.", PNAS, vol. 99, no. 22, 2002, pages 14098 - 14103, XP002486971 * |
Also Published As
Publication number | Publication date |
---|---|
IL197602A0 (en) | 2011-08-01 |
EP2061498A2 (fr) | 2009-05-27 |
CN101595124A (zh) | 2009-12-02 |
AU2007296429A1 (en) | 2008-03-20 |
JP2014050390A (ja) | 2014-03-20 |
CA2663498A1 (fr) | 2008-03-20 |
SG174784A1 (en) | 2011-10-28 |
BRPI0714987A2 (pt) | 2013-07-30 |
MX2009002787A (es) | 2009-08-27 |
RU2009113812A (ru) | 2010-10-20 |
NO20091267L (no) | 2009-06-04 |
WO2008033987A2 (fr) | 2008-03-20 |
JP2010503409A (ja) | 2010-02-04 |
KR20090059152A (ko) | 2009-06-10 |
EP2061498A4 (fr) | 2009-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008033987A3 (fr) | Compositions et procédés de prévention du cancer avec des cupredoxines | |
WO2008036932A3 (fr) | Compositions et procédés utilisant l'espèce boswellia | |
WO2007044084A3 (fr) | Inhibiteurs heterocycliques de mek et leurs procedes d'utilisation | |
WO2009109927A3 (fr) | Agonistes du récepteur glp-1 et ingrédients pharmaceutiques actifs apparentés pour le traitement du cancer | |
WO2008030273A3 (fr) | Compositions et procédés pour le diagnostic et le traitement du diabète de type 2 | |
WO2008048288A3 (fr) | Nouvelles nanoparticules et leur utilisation | |
WO2006108075A3 (fr) | Compositions et methodes accroissant la sensibilite aux medicaments et traitant les infections et maladies presentant une resistance aux medicaments | |
WO2008133722A3 (fr) | Anticorps et diagnostics | |
WO2010065709A3 (fr) | Dérivés d'acide hydroxamique, préparation et utilisations thérapeutiques de ceux-ci | |
WO2007109812A3 (fr) | Composes de potentialisation immunitaire | |
WO2007103490A3 (fr) | Système d'expression de composantes de traduction orthogonale dans des cellules hôtes d'eubactéries | |
MX358617B (es) | Formulaciones de inhibidores de dpp iv. | |
WO2006109312A3 (fr) | Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire | |
WO2006020060A3 (fr) | Composes de liaison aux proteines iap | |
WO2008064351A3 (fr) | (r)-n-stéréoisomères d'analogues 4,5-époxy-morphinanium saturé en position 7 et 8 | |
WO2008030412A3 (fr) | Inhibiteurs de la spiropipéridine bêta-sécrétase pour le traitement de la maladie d'alzheimer | |
WO2011008495A3 (fr) | Formulations d'arginase et procédés | |
WO2008117125A3 (fr) | Compositions capables de faciliter la pénétration à travers une barrière biologique | |
WO2007061939A3 (fr) | Dérivés de métabolites de l'inhibiteur de hdac fk228 | |
WO2009114725A3 (fr) | Mobilisation de cellules souches hématopoïétiques | |
WO2008136848A3 (fr) | Nouveaux anticorps anti-notch3 et leur utilisation dans la détection et le diagnostic d'une maladie | |
WO2009016181A3 (fr) | Agents pour l'imagerie optique | |
WO2008054698A3 (fr) | Composés de spiropipéridine inhibiteurs de la bêta-sécrétase pour le traitement de la maladie d'alzheimer | |
WO2007092496A3 (fr) | 7,9-dihydro-purin-8-one et analogues associés utilisés en tant qu'inhibiteurs de hsp90 | |
WO2007067519A3 (fr) | Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780041762.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07842403 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 575506 Country of ref document: NZ Ref document number: 2007296429 Country of ref document: AU Ref document number: 2663498 Country of ref document: CA Ref document number: 521/MUMNP/2009 Country of ref document: IN Ref document number: MX/A/2009/002787 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2009528468 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007842403 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2007296429 Country of ref document: AU Date of ref document: 20070913 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097007352 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2009113812 Country of ref document: RU Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0714987 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090313 |